HealthCare Global Enterprises shareholders approved all five resolutions at its 28th Annual General Meeting held on September 18, 2026, including the adoption of audited financial statements for FY26. However, the extension of a consultancy agreement with a related party drew significant opposition from public institutional investors.

The meeting was conducted via video conferencing in compliance with SEBI Listing Regulations and MCA circulars. Dr. B.S. Ajaikumar, Non-Executive Chairman, chaired the proceedings. Dr. Manish Mattoo, Executive Director and CEO, presented operational highlights for FY25-26.

Voting Participation

The company reported 45,831 shareholders on the record date. Voting participation was led by the promoter group, which polled votes on 99.99% of its outstanding shares. Public institutional investors voted on 88.21% of their holdings, while public non-institutional investors showed lower engagement at 7.48% to 7.56%, depending on the resolution.

Resolution Outcomes

All resolutions were passed with the requisite majority. The voting breakdown reveals distinct shareholder sentiment across different agenda items:

Scrutinizer Report Details

Mr. Pradeep B Kulkarni of V Sreedharan & Associates served as the scrutinizer. Remote e-voting was enabled from September 15 to September 17, 2026. Attendees used Insta-Poll for voting during the meeting.

Notable Voting Patterns

Resolution 4 (Related-Party Agreement): The resolution to extend the consultancy agreement with Mrs. Anjali Ajaikumar Rossi faced notable resistance. While promoter group members voted unanimously in favour, public institutional investors cast 14,537,053 votes against the proposal, representing 47.23% of their polled votes. This resulted in an overall dissent rate of 12.88%. The scrutinizer noted that four interested members holding 14,572,614 shares inadvertently voted in favour, and their votes were invalidated.

Director Reappointments: The reappointment of Ms. Simrun Mehta and Mr. Akshay Tanna received strong support but saw minor dissent from public institutional investors. For both resolutions, public institutions cast 95,030 votes against, accounting for 0.31% of their polled votes. Promoter and public non-institutional voters supported both directors unanimously or near-unanimously.

Governance

Eleven members attended the virtual meeting. Five shareholders registered as speakers, with two participating to seek clarifications from management. The board includes nine directors, with independent directors chairing audit, nomination, and risk committees.

Healthcare Global Enterprises will host a meeting with investors and analysts on September 22, 2026. The session is scheduled for 8:00 am in Mumbai.

The company issued the intimation pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was filed with both the National Stock Exchange of India Limited and BSE Limited on September 17, 2026.

Meeting Details

The interaction will take place during the Prabhudas Lilladher Private Limited conference. Company officials will engage with participants through one-to-one and group meetings.

Discussions will be based strictly on publicly available information. The company noted that changes may occur due to exigencies on the part of participants or the company.

Sunu Manuel, Company Secretary and Compliance Officer, signed the filing.